DOW JONES21,103.25-813.91 -3.71%
S&P 5002,482.34-102.25 -3.96%
NASDAQ7,379.15-320.95 -4.17%

Avadel Pharmaceuticals Q4 EPS $(0.07) Beats $(0.24) Estimate, Sales $10.995M Down From $20.92M YoY

Avadel Pharmaceuticals (NASDAQ:AVDL) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.24) by 70.83 percent. This is a 84.78 percent increase over losses of $(0.46) per share

Benzinga · 03/12/2020 11:12

Avadel Pharmaceuticals (NASDAQ:AVDL) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.24) by 70.83 percent. This is a 84.78 percent increase over losses of $(0.46) per share from the same period last year. The company reported $10.995 million in sales this quarter. This is a 47.44 percent decrease over sales of $20.92 million the same period last year.